Stratification of patients with intermediate‐risk prostate cancer
- 27 March 2015
- journal article
- Published by Wiley in BJU International
- Vol. 115 (6) , 907-912
Abstract
Objective: To identify an appropriate risk stratification system for intermediate‐risk prostate cancer ( PCa ). Patients and Methods: We reviewed the data on 1559 patients who were treated with radical prostatectomy ( RP ) at our institution between 2005 and 2013 and classified them according to National Comprehensive Cancer Network ( NCCN ) risk groups. For our analyses, intermediate‐risk PCa was designated as unfavourable intermediate‐risk PCa if it met at least one of the following two criteria: biopsy G leason score 4 + 3 and/or presence of ≥2 intermediate‐risk criteria. All other men with intermediate‐risk PCa were designated as having favourable intermediate‐risk disease. Postoperative outcomes, including biochemical recurrence ( BCR )‐free survival, were calculated and compared using the log‐rank test and Cox proportional hazards model. Results: In multivariable analysis, biopsy G leason score 4 + 3 and multiple (≥2) intermediate‐risk criteria were observed to be independent predictors of BCR risk among men in the intermediate‐risk group undergoing RP . The favourable intermediate‐risk group had a significantly higher 5‐year BCR ‐free survival compared with the unfavourable intermediate‐risk group (87.5 vs 66.5%; P < 0.001). The unfavourable intermediate‐risk group had significantly higher 5‐year BCR ‐free survival than the high‐risk group (66.5 vs 47.9%; P < 0.001) while the favourable intermediate‐risk group had significantly lower 5‐year BCR ‐free survival than the low‐risk group (87.5 vs 93.5%; P = 0.002). Conclusions: A marked heterogeneity exists in the biochemical outcomes of contemporary patients with intermediate‐risk PCa who undergo definitive RP . According to biopsy G leason score and number of intermediate‐risk criteria present, the intermediate‐risk group should be sub‐divided into those with favourable and unfavourable intermediate‐risk disease.Keywords
This publication has 23 references indexed in Scilit:
- Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH databaseThe Prostate, 2012
- Gleason Score 7 Prostate Cancer on Needle Biopsy: Relation of Primary Pattern 3 or 4 to Pathological Stage and Progression After Radical ProstatectomyJournal of Urology, 2011
- Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution seriesUrologic Oncology: Seminars and Original Investigations, 2011
- Evolution of the clinical presentation of men undergoing radical prostatectomy for high‐risk prostate cancerBJU International, 2011
- Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate CancerJournal of Clinical Oncology, 2011
- Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate gradeBJU International, 2010
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate CancerJournal of Clinical Oncology, 2010
- Contemporary Risk Profile of Prostate Cancer in the United StatesJNCI: Journal of the National Cancer Institute, 2009
- Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancerBJU International, 2008
- Risk Stratification of Men with Gleason Score 7 to 10 Tumors by Primary and Secondary Gleason Score: Results from the SEARCH DatabaseUrology, 2007